CLOs on the Move

Applied Clinical Research Institute

www.agmg.com

 
Applied Clinical Research Institute is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

McFarlane Medical

McFarlane Medical is a Geneva, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

R2 Technologies

Glacial Rx™ is the first age spot removal treatment that uses patented cooling technology to freeze melanin at the source, soothing your skin while effectively removing those annoying age spots.

Ossur

Ossur is in the business of improving people`s mobility. As a leading global company in non-invasive orthopaedics, we deliver advanced and innovative technologies within the fields of prosthetics, braces, supports and compression therapy. Determined to restore maximum biological function to those in need, Össur has more than thirty years` experience in the design and production of high-tech orthopaedic devices. Our work, however, is as much about people as it is about products. Their comfort, confidence and rehabilitation are central to our endeavors. We never forget that every time we develop a product or service, we are helping someone else to build a better life.

R G I Medical Manafacturing Inc

R G I Medical Manafacturing Inc is a Gainesville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.